|
Middle East Low Wages and Govt Support Pushing China Ahead of other Asia-Pacific
Biotech Markets
We have recently released a new research report, "Asia Pacific
Biotechnology
Market (2008-2012)", which says that the Chinese biotechnology market is
expected to grow at a CAGR of over 23% during 2007-2012. This will
enable
the country to represent around 25% of the Asia Pacific biotech market
revenue by 2012.
The report has identified lower wages in China compared to other
Asian-Pacific countries as the main reason for high growth in the
country's
biotechnology market. For instance, wages in China are 10% to 15% lower
than
that in India, one of the low-cost countries. Moreover, with hire and
fire
policy, the labor policies in China are more liberal, helping the
biotech
industry to increase productivity and reduce cost.
The Chinese government strongly supports its biotech industry and has
been
aggressively investing in the industry to foster growth, says the
report.
Apparently, the annual investments by the government surged at a CAGR of
86.12% during 2001-2005 to US$ 1.2 Billion in 2005 from US$ 100 Million
in
2001. In addition, we expect that the investment will rise to US$ 8.8
Billion by the end of 2010 as the government intends to make China one
of
the leading biotech markets in the world.
China is just one of the many Asia-Pacific countries discussed in the
"Asia-Pacific Biotechnology Market (2008-2012)". The report provides
comprehensive overview on the biotechnology market of countries like
Japan,
Taiwan and Singapore. It highlights the fact that Asia-Pacific
biotechnology
markets differ from each other remarkably in terms of infrastructure,
talent
pool, size, funding, growth, and potential as an outsourcing
destination. It
gives valuable information along with s tatistical data to
pharmaceutical &
biotechnology companies and investors planning to invest in these
markets,
helping them to plan their strategies according to the individual
market.
The report also provides information on the market size, segmentation,
structure, growth, future prospects, success and risk factors, and
evolving
trends in technology development.
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. It
has a team of industry experts who analyze data collected from credible
sources. They provide industry insights and analysis that helps
corporations to take timely and accurate business decision in today's
globally competitive environment.
For more information visit: http://www.rncos.com/Report/IM138.htm
Current Industry News: http://www.rncos.com/Blog/
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com®, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.com® or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.com® endorsing the content as a recommendation to buy or sell stock.
Would you like to see your news and articles here? GO>>;;
|
